# Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

> **NCT00813501** · — · TERMINATED · sponsor: **City of Hope Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Infection
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic-Myeloproliferative Diseases
- Neuroblastoma
- Therapy-related Toxicity

## Interventions

- **BIOLOGICAL:** immunosuppressive therapy
- **OTHER:** immunological diagnostic method
- **PROCEDURE:** allogeneic hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT00813501
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Terminated at the request of the study sponsor
- **Last updated:** 2011-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813501, "Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00813501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*